Suppr超能文献

基于风险分组的甲状腺癌治疗。

Treatment of thyroid cancer based on risk groups.

作者信息

Shaha Ashok

机构信息

Memorial Sloan-Kettering Cancer Center, Head and Neck Service, 1275 York Avenue, New York, NY 10021, USA.

出版信息

J Surg Oncol. 2006 Dec 15;94(8):683-91. doi: 10.1002/jso.20697.

Abstract

The understanding of the prognostic factors and risk groups is crucial in the management of well differentiated thyroid cancer. The important prognostic factors are age, grade of tumor, extrathyroidal extension, size of tumor, and distant metastases. Based on these prognostic factors, patients can be divided into low-, intermediate-, and high-risk groups. The treatment decisions should be based on risk group analysis. Extent of thyroidectomy and adjuvant therapy can be based on the risk group analysis. The histopathologic studies are very important to distinguish well differentiated from the tall cell, insular, and poorly differentiated thyroid cancer.

摘要

了解预后因素和风险分组对于分化型甲状腺癌的管理至关重要。重要的预后因素包括年龄、肿瘤分级、甲状腺外侵犯、肿瘤大小和远处转移。基于这些预后因素,患者可分为低危、中危和高危组。治疗决策应基于风险分组分析。甲状腺切除范围和辅助治疗可基于风险分组分析。组织病理学研究对于区分高细胞型、岛状和低分化甲状腺癌与分化良好的甲状腺癌非常重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验